Journal Of Clinical Oncology (jco) Podcast
Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:07:27
- Mas informaciones
Informações:
Sinopsis
A discussion of a phase 2 trial of a MEK inhibitor in patients with V600 BRAF mutations and consideration of other relevant results with targeted therapies in this population.
